During the past decade, Budai Irgalmasrendi Kórház KHT. II. Reumatológia conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Budai Irgalmasrendi Kórház KHT. II. Reumatológia" #1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Budai Irgalmasrendi Kórház KHT. II. Reumatológia" are "Rheumatoid Arthritis" (3 trials). Many other conditions were trialed in "Budai Irgalmasrendi Kórház KHT. II. Reumatológia" in a lesser frequency.

Most popular intervention types in "Budai Irgalmasrendi Kórház KHT. II. Reumatológia" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Methotrexate" (2 trials), "Tocilizumab" (2 trials), "Leflunomide" (1 trials), "Ocrelizumab" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Budai Irgalmasrendi Kórház KHT. II. Reumatológia" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Budai Irgalmasrendi Kórház KHT. II. Reumatológia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Budai Irgalmasrendi Kórház KHT. II. Reumatológia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Budai Irgalmasrendi Kórház KHT. II. Reumatológia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".